The present invention relates to a variant of AIMP2 lacking exon 2, named as AIMP2-DX2, which is specifically expressed in cancer cells. The AIMP2-DX2 protein and gene can be successfully used in the development of diagnosis and treatment of cancer.

 
Web www.patentalert.com

< Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase

> Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor
~ 00481